Compare LYFT Inc (LYFT) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs GeneDx Holdings Corp — how do they compare? LYFT Inc trades at $15.22 (market cap $5.86B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: LYFT Inc is far larger — about 3.3× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| LYFT | WGS | |
|---|---|---|
Market Cap | $5.86B | $1.80B |
Sector | Industrials | Technology |
52-Week High | $24.57 | $167.51 |
52-Week Low | $12.65 | $34.51 |
Enterprise Value | $5.39B | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $15.19, down 2.13% today, with a bullish technical signal from moving averages and ADX indicators. The stock shows strong fundamental improvement, with revenue growing to $6.32B in 2025 and net income surging to $2.84B, yielding a net margin of 43.82%. Recent developments include expansion into New York City's taxi market and a new CTO appointment. Valuation metrics appear attractive with a P/E of 2.26 and P/S of 0.98, below industry averages.
The outlook for Lyft is cautiously optimistic, supported by profitability turnaround and strategic expansions, but tempered by recent earnings misses and intense competition. Upside potential exists toward the consensus price target of $17.86, representing 17.6% upside from current levels. Key risks include competitive pressures from Uber, pricing transparency concerns, and execution risks in autonomous vehicle partnerships. Investor sentiment remains mixed with 37% buy ratings versus 58% hold recommendations.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
